XML 141 R41.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Commitments and Contingencies (Details Narrative) - USD ($) |  |  |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | ---
Mar. 19, 2022 | Feb. 15, 2022 | Nov. 27, 2018 | Aug. 15, 2018 | Mar. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Reimbursement or royalty paid |  |  |  |  |  |  | $ 0
Contingent payments due |  |  |  |  |  | $ 0 |
Global and BioLife Sciences [Member] |  |  |  |  |  |  |
Sale of royalty, percentage |  | 20.00% |  |  |  |  |
Equity Method Investment, Ownership Percentage |  | 20.00% |  |  |  |  |
Royalty Agreement [Member] |  |  |  |  |  |  |
Royalty, percentage |  |  |  | 50.00% |  |  |
Royalty Agreement [Member] | Chemia Corporation [Member] |  |  |  |  |  |  |
Royalty, percentage |  |  |  | 50.00% |  |  |
Sale of royalty, percentage |  |  | 5.00% |  |  |  |
License Agreement [Member] |  |  |  |  |  |  |
Sale of royalty, percentage | 5.50% |  |  |  |  |  |
Development cost, percent | 50.00% |  |  |  |  |  |
Costs Incurred, Development Costs | $ 1,250,000 |  |  |  |  |  |
Development Costs, Period Cost |  |  |  |  | $ 152,000 | 200,000 | $ 0
Contingent legal fees |  |  |  |  |  | $ 0 |

X
- Definition Contingent legal fees. + References No definition available. + Details
Name: | IMPB_ContingentLegalFees
Namespace Prefix: | IMPB_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contingent payments due. + References No definition available. + Details
Name: | IMPB_ContingentPaymentsDue
Namespace Prefix: | IMPB_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Development cost percent. + References No definition available. + Details
Name: | IMPB_DevelopmentCostPercent
Namespace Prefix: | IMPB_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Re imbursement or royalty paid. + References No definition available. + Details
Name: | IMPB_ReimbursementOrRoyaltyPaid
Namespace Prefix: | IMPB_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty percentage. + References No definition available. + Details
Name: | IMPB_RoyaltyPercentage
Namespace Prefix: | IMPB_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sale of royalty percentage. + References No definition available. + Details
Name: | IMPB_SaleOfRoyaltyPercentage
Namespace Prefix: | IMPB_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 932 -SubTopic 235 -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482274/932-235-50-18 + Details
Name: | us-gaap_CostsIncurredDevelopmentCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 932 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-10(c)(7)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479664/932-10-S99-1 + Details
Name: | us-gaap_DevelopmentCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=IMPB_GlobalAndBioLifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=IMPB_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=IMPB_ChemiaCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=IMPB_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |